Founded as a spinout of Oxford University and continuing the work initiated by MIT’s Mind Machine Project, ni2o is dedicated to developing AI-powered brain-computer interfaces (BCIs). The company's core mission is to treat neurological disorders and enhance cognitive functions. Their product lineup includes innovative solutions like KIWI and tKIWI, designed to address critical medical needs through advanced neural input-output technology.
Notable figures associated with ni2o include a global team of seasoned entrepreneurs, technologists, and neuroscientists. The company has garnered attention for its groundbreaking approach to BCIs, leveraging artificial intelligence to create impactful medical treatments. Their achievements in the field have positioned them as a significant player in the intersection of neuroscience and AI, contributing to advancements in both medical therapy and cognitive enhancement.
